Graham Juan

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 96% 68% 82%
Transactions
8 12% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Graham Juan's trades of Perspective Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
342.74
Quantity 17,322
Value US$1,970,091
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
233.26
Quantity 49,713 +45.5%
Value US$1,286,566
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
16.95
Quantity 1,050 -1.4%
Value US$17,797
US FibroGen Inc (FGEN)
Transaction date
Proposed sale
Price
17.04
Quantity 1,406
Value US$23,956
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 2,344 -3.1%
Value US$47,342
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 1,456 -1.9%
Value US$29,407
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
20.20
Quantity 1,112 -1.4%
Value US$22,459
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
21.16
Quantity 2,749 -3.8%
Value US$58,158
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
14.50
Quantity 1,407 -2.6%
Value US$20,402
US FibroGen Inc (FGEN)
Transaction date
Sale
Price
14.90
Quantity 781 -1.4%
Value US$11,637
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
15.47
Quantity 478 -0.9%
Value US$7,395
US FibroGen Inc (FGEN)
Transaction date
Planned sale
Price
14.84
Quantity 5,263 -9.4%
Value US$78,103
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-01 2025-03-28
B Purchase
42,296 +22.9%
110.31
US$1,556,906 		42,296 +22.9% 110.31 US$1,556,906
2023-06-08 2023-06-08
US FibroGen Inc (FGEN)
PrS Proposed sale
17,322
342.74
US$1,970,091 		17,322 342.74 US$1,970,091
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
49,713 +45.5%
233.26
US$1,286,566 		49,713 +45.5% 233.26 US$1,286,566
2023-06-09 2023-06-07
US FibroGen Inc (FGEN)
S Sale
1,050 -1.4%
16.95
US$17,797 		1,050 -1.4% 16.95 US$17,797
2023-06-07 2023-06-07
US FibroGen Inc (FGEN)
PrS Proposed sale
1,406
17.04
US$23,956 		1,406 17.04 US$23,956
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
2,344 -3.1%
20.20
US$47,342 		2,344 -3.1% 20.20 US$47,342
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
1,456 -1.9%
20.20
US$29,407 		1,456 -1.9% 20.20 US$29,407
2023-03-10 2023-03-10
US FibroGen Inc (FGEN)
S Sale
1,112 -1.4%
20.20
US$22,459 		1,112 -1.4% 20.20 US$22,459
2023-03-10 2023-03-08
US FibroGen Inc (FGEN)
S Sale
2,749 -3.8%
21.16
US$58,158 		2,749 -3.8% 21.16 US$58,158
2022-12-14 2022-12-12
US FibroGen Inc (FGEN)
PlS Planned sale
1,407 -2.6%
14.50
US$20,402 		1,407 -2.6% 14.50 US$20,402
2022-12-14 2022-12-09
US FibroGen Inc (FGEN)
S Sale
781 -1.4%
14.90
US$11,637 		781 -1.4% 14.90 US$11,637
2022-12-15 2022-12-08
US FibroGen Inc (FGEN)
PlS Planned sale
478 -0.9%
15.47
US$7,395 		478 -0.9% 15.47 US$7,395
2022-12-15 2022-12-08
US FibroGen Inc (FGEN)
PlS Planned sale
5,263 -9.4%
14.84
US$78,103 		5,263 -9.4% 14.84 US$78,103